AstraZeneca sets ambition to deliver $80 billion annual by 2030 

We've set our bold ambition to deliver $80bn in annual revenue by 2030, up from $45bn in 2023. This will be achieved through significant growth in our existing oncology, biopharmaceuticals and rare disease portfolio, and by launching 20 new medicines for patients before the end of the decade. And, to drive sustained growth beyond 2030, we’ll continue investing in, and rapidly advancing, transformative new technologies and platforms that will shape the future of medicine.
As we enter a new era of growth, we will continue to decouple carbon emissions from our increase in revenue, halving emissions across our value chain by 2030.
#AZN #WhatScienceCanDo
------------------------------------------------------------
Global site: www.astrazeneca.com/
Careers site: careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazeneca

Наука